Search research articles
Contact Us
Filters
Showing results (161-170 of 183) with videos related to
Page
of 19
Sort By:
Disease Markers
|
January 17, 2019
Combination of Proteasome and Histone Deacetylase Inhibitors Overcomes the Impact of Gain-of-Function p53 Mutations
Xiangbing Meng, Shujie Yang, Yujun Li, et al.
Nucleic Acids Research
|
April 3, 2012
Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers
Kristina W Thiel, Luiza I Hernandez, Justin P Dassie, et al.
Nature Biotechnology
|
August 25, 2009
Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors
Justin P Dassie, Xiu-Ying Liu, Gregory S Thomas, et al.
International Journal of Molecular Sciences
|
March 15, 2019
Molecular Characterization of Non-responders to Chemotherapy in Serous Ovarian Cancer
Megan E McDonald, Erin A Salinas, Eric J Devor, et al.
Scientific Reports
|
March 17, 2021
Creation and validation of models to predict response to primary treatment in serous ovarian cancer
Jesus Gonzalez Bosquet, Eric J Devor, Andreea M Newtson, et al.
Nature Communications
|
July 11, 2026
Patient-derived model capturing hypoxia and extracellular matrix remodelling of immunologically cold high-grade serous tumours
Simona Plesselova, Hailey Axemaker, Kristin Calar, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 5, 2017
Placenta-Specific Protein 1 Expression in Human Papillomavirus 16/18-Positive Cervical Cancers Is Associated With Tumor Histology
Eric J Devor, Henry D Reyes, Jesus Gonzalez-Bosquet, et al.
Cancers
|
May 23, 2018
AZD1775 Increases Sensitivity to Olaparib and Gemcitabine in Cancer Cells with p53 Mutations
Xiangbing Meng, Jianling Bi, Yujun Li, et al.
Nature Nanotechnology
|
December 6, 2017
Synthetically lethal nanoparticles for treatment of endometrial cancer
Kareem Ebeid, Xiangbing Meng, Kristina W Thiel, et al.
Gynecologic Oncology
|
November 3, 2015
Downregulation of FOXO1 mRNA levels predicts treatment failure in patients with endometrial pathology conservatively managed with progestin-containing intrauterine devices
Henry D Reyes, Matthew J Carlson, Eric J Devor, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 183) with videos related to
Sort By:
Page
of 19
Disease Markers
|
January 17, 2019
Combination of Proteasome and Histone Deacetylase Inhibitors Overcomes the Impact of Gain-of-Function p53 Mutations
Xiangbing Meng, Shujie Yang, Yujun Li, et al.
Nucleic Acids Research
|
April 3, 2012
Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers
Kristina W Thiel, Luiza I Hernandez, Justin P Dassie, et al.
Nature Biotechnology
|
August 25, 2009
Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors
Justin P Dassie, Xiu-Ying Liu, Gregory S Thomas, et al.
International Journal of Molecular Sciences
|
March 15, 2019
Molecular Characterization of Non-responders to Chemotherapy in Serous Ovarian Cancer
Megan E McDonald, Erin A Salinas, Eric J Devor, et al.
Scientific Reports
|
March 17, 2021
Creation and validation of models to predict response to primary treatment in serous ovarian cancer
Jesus Gonzalez Bosquet, Eric J Devor, Andreea M Newtson, et al.
Nature Communications
|
July 11, 2026
Patient-derived model capturing hypoxia and extracellular matrix remodelling of immunologically cold high-grade serous tumours
Simona Plesselova, Hailey Axemaker, Kristin Calar, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 5, 2017
Placenta-Specific Protein 1 Expression in Human Papillomavirus 16/18-Positive Cervical Cancers Is Associated With Tumor Histology
Eric J Devor, Henry D Reyes, Jesus Gonzalez-Bosquet, et al.
Cancers
|
May 23, 2018
AZD1775 Increases Sensitivity to Olaparib and Gemcitabine in Cancer Cells with p53 Mutations
Xiangbing Meng, Jianling Bi, Yujun Li, et al.
Nature Nanotechnology
|
December 6, 2017
Synthetically lethal nanoparticles for treatment of endometrial cancer
Kareem Ebeid, Xiangbing Meng, Kristina W Thiel, et al.
Gynecologic Oncology
|
November 3, 2015
Downregulation of FOXO1 mRNA levels predicts treatment failure in patients with endometrial pathology conservatively managed with progestin-containing intrauterine devices
Henry D Reyes, Matthew J Carlson, Eric J Devor, et al.
Page
of 19